Related by context. Frequent words. (Click for all words.) 71 Acute Myeloid Leukemia 69 metastatic renal cell carcinoma 69 acute myelogenous leukemia AML 68 cutaneous T cell 68 acute myeloid leukemia AML 67 myelodysplastic syndromes MDS 67 Chronic Lymphocytic Leukemia 66 relapsed refractory multiple myeloma 66 relapsed multiple myeloma 66 L Annamycin 66 Amrubicin 66 myelodysplastic syndrome MDS 66 chronic lymphocytic leukemia CLL 65 systemic lupus erythematosus SLE 65 Voreloxin 65 HER2 positive metastatic breast 65 lymphoma CTCL 65 refractory multiple myeloma 64 humanized anti 64 lupus nephritis 63 hypoparathyroidism 63 relapsing remitting multiple sclerosis 63 Pivotal Phase 63 Completes Enrollment 63 Alemtuzumab 63 Lenalidomide 62 systemic lupus erythematosus 62 Pivotal Phase III 62 idiopathic pulmonary fibrosis IPF 62 Initiates Phase 62 gastrointestinal stromal tumors 62 Phase III Trial 62 glioblastoma multiforme GBM 62 chronic myeloid leukemia CML 62 castration resistant prostate cancer 62 cell chronic lymphocytic 62 non squamous 61 TORISEL 61 decitabine 61 Nexavar ® 61 hormone refractory prostate cancer 61 hepatocellular carcinoma HCC 61 Torisel 61 Bortezomib 61 hepatitis C HCV 61 myelofibrosis 61 paroxysmal nocturnal hemoglobinuria PNH 61 Monotherapy 61 non alcoholic steatohepatitis 61 Ofatumumab 61 secondary hyperparathyroidism 61 Relapsed 61 follicular non 60 Pirfenidone 60 Trastuzumab 60 Chronic Hepatitis C 60 imatinib mesylate 60 Laquinimod 60 Phase III Clinical Trial 60 unresectable 60 Clinical Trial Results 60 relapsed refractory 60 advanced NSCLC 60 aHUS 60 hypoxia inducible factor 60 biologic therapy 60 Rituximab 60 Pivotal Trial 60 Acute Lymphoblastic Leukemia 60 Irinotecan 60 CABP 60 follicular lymphoma 60 metastatic colorectal cancer 60 tanespimycin 60 bone metastasis 60 pseudobulbar affect PBA 60 clofarabine 60 refractory Hodgkin lymphoma 60 NSCLC 59 medullary thyroid cancer 59 ALN TTR# 59 dacarbazine 59 Bevacizumab 59 hematologic cancers 59 Azedra 59 Cloretazine R VNP#M 59 diabetic nephropathy 59 Drug Candidate 59 HRPC 59 orphan medicinal product 59 Monoclonal Antibody 59 IV melanoma 59 tamibarotene 59 pancreatic insufficiency 59 6R BH4 59 chronic myelogenous leukemia CML 59 IMC A# 59 cystic fibrosis CF 59 eculizumab 59 Sym# 59 renal cell carcinoma